{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:06:08Z","timestamp":1788023168047,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"American Heart Association, Greater Southeast Affiliate","award":["10GRNT4300073"],"award-info":[{"award-number":["10GRNT4300073"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.bbadis.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:30:20Z","timestamp":1478737820000},"page":"428-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients"],"prefix":"10.1016","volume":"1863","author":[{"given":"Erica J.","family":"Fratz-Berilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Breydo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Puy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir N.","family":"Uversky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.11.011_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1098\/rstb.1976.0005","article-title":"Mechanism and stereochemistry of enzymic reactions involved in porphyrin biosynthesis","volume":"273","author":"Akhtar","year":"1976","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0010","series-title":"Handbook of Porphyrin Science","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1142\/9789814407755_0001","article-title":"Toward Heme: 5-Aminolevulinate Synthase and Initiation of Porphyrin Synthesis","volume":"26","author":"Fratz","year":"2013"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0015","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.bbapap.2010.12.015","article-title":"Molecular enzymology of 5-aminolevulinate synthase, the gatekeeper of heme biosynthesis","volume":"11","author":"Hunter","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6603(08)60875-2","article-title":"Molecular regulation of heme biosynthesis in higher vertebrates","volume":"51","author":"May","year":"1995","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0025","first-page":"102","article-title":"5-Aminolevulinate synthase: catalysis of the first step of heme biosynthesis","volume":"55","author":"Hunter","year":"2009","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0030","series-title":"Handbook of Porphyrin Science, Porphyrias and Sideroblastic Anemias","first-page":"44","article-title":"Sideroblastic Anemias: Molecular Basis, Pathophysiology, and Clinical Aspects","volume":"29","author":"Bottomley","year":"2014"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF02110031","article-title":"Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia","volume":"27","author":"Bottomley","year":"1995","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0040","series-title":"Handbook of Porphyrin Science","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1142\/9789814407755_0027","article-title":"Heme Biosynthesis and Pathophysiology of Porphyrias","volume":"29","author":"Karim","year":"2013"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2008.08.003","article-title":"C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload","volume":"83","author":"Whatley","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12185-010-0688-4","article-title":"Hereditary sideroblastic anemia: pathophysiology and gene mutations","volume":"92","author":"Harigae","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0055","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V93.5.1757","article-title":"Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis","volume":"93","author":"Cotter","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0060","doi-asserted-by":"crossref","first-page":"28943","DOI":"10.1074\/jbc.M111.306423","article-title":"X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the beta-subunit of succinyl-CoA synthetase (SUCLA2)","volume":"287","author":"Bishop","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0065","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/hmg\/dds531","article-title":"Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP)","volume":"22","author":"Ducamp","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.1967.00300040086015","article-title":"Pyridoxine-responsive sideroblastic anemia due to antituberculous drugs","volume":"120","author":"Haden","year":"1967","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0075","doi-asserted-by":"crossref","DOI":"10.4081\/hr.2011.e2","article-title":"Severe isoniazid related sideroblastic anemia","volume":"3","author":"Piso","year":"2011","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0080","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1742-1241.1990.tb10169.x","article-title":"Anti-tuberculous drugs and sideroblastic anaemia","volume":"44","author":"Sharp","year":"1990","journal-title":"Br. J. Clin. Pract."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-2952(97)00252-9","article-title":"Mechanisms of the inhibition of human erythrocyte pyridoxal kinase by drugs","volume":"54","author":"Laine-Cessac","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0090","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0021-9258(18)64133-X","article-title":"Pyridoxal phosphokinases. II. Effects of inhibitors","volume":"236","author":"McCormick","year":"1961","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/clpt.2010.355","article-title":"A fresh look at the mechanism of isoniazid-induced hepatotoxicity","volume":"89","author":"Metushi","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0100","first-page":"513","article-title":"Nicotinyl and isonicotinyl hydrazones of pyridoxal","volume":"43","author":"Sah","year":"1954","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1979.tb03699.x","article-title":"Haem synthesis in sideroblastic anaemia","volume":"42","author":"Konopka","year":"1979","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1471-2105-10-273","article-title":"The B6 database: a tool for the description and classification of vitamin B6-dependent enzymatic activities and of the corresponding protein families","volume":"10","author":"Percudani","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apa.12908","article-title":"Elevated transaminases are common in children on prophylactic treatment for tuberculosis","volume":"104","author":"Leeb","year":"2015","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0120","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/j.transproceed.2009.01.118","article-title":"Successful liver transplantation in antituberculosis therapy\u2013induced acute fulminant hepatic failure","volume":"41","author":"Schneider","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0125","first-page":"8249","article-title":"Successful diagnosis of hyperpyrexia induced by isoniazid in a child with suspected extra-pulmonary tuberculosis","volume":"8","author":"Qu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0130","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2174\/138920007782798216","article-title":"Isoniazid: metabolic aspects and toxicological correlates","volume":"8","author":"Paolo","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jgh.12516","article-title":"Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress","volume":"29","author":"Boelsterli","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jhep.2006.01.027","article-title":"Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice","volume":"45","author":"Chowdhury","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0145","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/tx300341r","article-title":"Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats","volume":"25","author":"Metushi","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0150","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/bcp.12885","article-title":"Mechanism of isoniazid-induced hepatotoxicity: then and now","volume":"81","author":"Metushi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0155","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1021\/acs.biochem.5b00407","article-title":"Human erythroid 5-aminolevulinate synthase mutations associated with X-linked protoporphyria disrupt the conformational equilibrium and enhance product release","volume":"54","author":"Fratz","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0160","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0021-9258(18)54191-0","article-title":"Expression of mammalian 5-aminolevulinate synthase in Escherichia coli. Overproduction, purification, and characterization","volume":"268","author":"Ferreira","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093078","article-title":"Expression of murine 5-aminolevulinate synthase variants causes protoporphyrin IX accumulation and light-induced mammalian cell death","volume":"9","author":"Fratz","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0170","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1021\/bi961296h","article-title":"Mutations at a glycine loop in aminolevulinate synthase affect pyridoxal phosphate cofactor binding and catalysis","volume":"35","author":"Gong","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0175","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000459096","article-title":"Comparisons and modifications of the colorimetric assay for delta-aminolevulinic acid synthase","volume":"28","author":"Lien","year":"1982","journal-title":"Enzyme"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/abio.1996.0238","article-title":"Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase","volume":"237","author":"Kuzmic","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0195","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0076-6879(09)67010-5","article-title":"DynaFit\u2013a software package for enzymology","volume":"467","author":"Kuzmic","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2119\/molmed.2013.00003","article-title":"Molecular expression and characterization of erythroid-specific 5-aminolevulinate synthase gain-of-function mutations causing X-linked protoporphyria","volume":"19","author":"Bishop","year":"2013","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ajh.22125","article-title":"Pyrazinamide-induced sideroblastic anemia","volume":"87","author":"Colucci","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0215","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1074\/jbc.M109.066548","article-title":"Serine 254 enhances an induced fit mechanism in murine 5-aminolevulinate synthase","volume":"285","author":"Lendrihas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0220","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bmj.2.4787.735","article-title":"Treatment of pulmonary tuberculosis with isoniazid; an interim report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee","volume":"2","author":"Crofton","year":"1952","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.42.2.222","article-title":"Pyridoxine-responsive anemia in a patient receiving isoniazid","volume":"42","author":"Redleaf","year":"1962","journal-title":"Dis. Chest."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2141.1965.tb00088.x","article-title":"Antituberculous drugs and sideroblastic anaemia","volume":"11","author":"Verwilghen","year":"1965","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood.V27.3.352.352","article-title":"Pyridoxine-responsive anemia conditioned by isonicotinic acid hydrazide","volume":"27","author":"McCurdy","year":"1966","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0240","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1651-2227.2010.01696.x","article-title":"Pyridoxal-5-phosphate plasma concentrations in children receiving tuberculosis chemotherapy including isoniazid","volume":"99","author":"Cilliers","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0245","first-page":"99","article-title":"Anemia with hypersideroblastosis during anti-tuberculosis therapy. Cure with vitamin therapy","volume":"20","author":"Viv\u00e9s","year":"1978","journal-title":"Nouv. Rev. Fr. Hematol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2141.1965.tb00089.x","article-title":"Experimental sideroblastic anaemia","volume":"11","author":"Harriss","year":"1965","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0255","first-page":"92","article-title":"Bone marrow delta-aminolevulinic acid synthetase activity in experimental sideroblastic anemia","volume":"84","author":"Tanaka","year":"1974","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0260","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood.V46.4.625.625","article-title":"Abnormal erythroid maturation in mice induced by isoniazid","volume":"46","author":"Morse","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2016.11.011_bb0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/0470846526.ch15","article-title":"Mechanisms for isoniazid action and resistance","volume":"217","author":"Miesel","year":"1998","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0270","doi-asserted-by":"crossref","first-page":"27743","DOI":"10.1074\/jbc.M111.333385","article-title":"A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria","volume":"287","author":"Niki","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0275","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.2235848100","article-title":"The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance","volume":"100","author":"Rawat","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1389201023378328","article-title":"Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis","volume":"3","author":"Schroeder","year":"2002","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0285","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1286-4579(00)00359-2","article-title":"The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis","volume":"2","author":"Slayden","year":"2000","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0290","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1365-2958.2000.02145.x","article-title":"Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis","volume":"38","author":"Slayden","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0295","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1365-2958.2006.05467.x","article-title":"Mechanisms of action of isoniazid","volume":"62","author":"Timmins","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0300","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.bmcl.2013.03.006","article-title":"Isoniazid: radical-induced oxidation and reduction chemistry","volume":"23","author":"Rickman","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0305","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0003-2013","article-title":"The molecular genetics of mycolic acid biosynthesis","volume":"2","author":"Pawe\u0141czyk","year":"2014","journal-title":"Microbiol. Spect."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0310","doi-asserted-by":"crossref","first-page":"23025","DOI":"10.1074\/jbc.M609330200","article-title":"Transient kinetic studies support refinements to the chemical and kinetic mechanisms of aminolevulinate synthase","volume":"282","author":"Hunter","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0315","doi-asserted-by":"crossref","first-page":"22915","DOI":"10.1074\/jbc.M114.574731","article-title":"Unstable reaction intermediates and hysteresis during the catalytic cycle of 5-aminolevulinate synthase: implications from using pseudo and alternate substrates and a promiscuous enzyme variant","volume":"289","author":"Stojanovski","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0320","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1074\/jbc.274.18.12222","article-title":"Pre-steady-state reaction of 5-aminolevulinate synthase. Evidence for a rate-determining product release","volume":"274","author":"Hunter","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0325","doi-asserted-by":"crossref","first-page":"13704","DOI":"10.1074\/jbc.M109.074237","article-title":"Targeting the active site gate to yield hyperactive variants of 5-aminolevulinate synthase","volume":"285","author":"Lendrihas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0330","doi-asserted-by":"crossref","first-page":"44660","DOI":"10.1074\/jbc.M203584200","article-title":"Transient state kinetic investigation of 5-aminolevulinate synthase reaction mechanism","volume":"277","author":"Zhang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0335","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/sj.emboj.7600792","article-title":"Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans","volume":"24","author":"Astner","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0340","first-page":"2145","article-title":"Catalytically active alkaline molten globular enzyme: effect of pH and temperature on the structural integrity of 5-aminolevulinate synthase","volume":"2014","author":"Stojanovski","year":"1844","journal-title":"Biochim. Biophys. Acta Protein Proteomic."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0345","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1172\/JCI6816","article-title":"Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia","volume":"105","author":"Furuyama","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2016.11.011_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135896","article-title":"Identification of the mitochondrial heme metabolism complex","volume":"10","author":"Medlock","year":"2015","journal-title":"PLoS ONE"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916302939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916302939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T17:12:47Z","timestamp":1692551567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916302939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0925443916302939"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.011","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}